Aldosterone Synthase Inhibition in Diabetes and Cardiorenal Metabolic Disease
Journal of Diabetes · 2026-07 · 18 (7)
DOI: 10.1111/1753-0407.70253 ↗Kurz gefasst
Editorial in der Zeitschrift Journal of Diabetes, online erschienen am 10.07.2026. Verfasst von Zachary Bloomgarden. Beteiligte Einrichtung: Department of Medicine, Division of Endocrinology, Diabetes and Bone Disease, Icahn School of Medicine at Mount Sinai, New York, New York, USA. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Medicine, Division of Endocrinology, Diabetes and Bone Disease, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
ORCID-Profile: Zachary Bloomgarden
Zitieren
APA
Bloomgarden, Z. (2026). Aldosterone Synthase Inhibition in Diabetes and Cardiorenal Metabolic Disease. Journal of Diabetes, 18(7). https://doi.org/10.1111/1753-0407.70253
Vancouver
Bloomgarden Z. Aldosterone Synthase Inhibition in Diabetes and Cardiorenal Metabolic Disease. Journal of Diabetes. 2026;18(7). doi:10.1111/1753-0407.70253
BibTeX
@article{Bloomgarden2026,
author = {Bloomgarden, Zachary},
title = {Aldosterone Synthase Inhibition in Diabetes and Cardiorenal Metabolic Disease},
journal = {Journal of Diabetes},
year = {2026},
volume = {18},
number = {7},
doi = {10.1111/1753-0407.70253}
}
EUVIMED